Mary Jackson recounts personal stories on choosing and becoming an infectious diseases researcher and shares her wisdom with younger trainees and scientists.
Elena Lian, mentored by Dr. Mary Jackson, wins first place in the Foundational, Advanced Career poster category.
Diana Lowe (Telling lab), Elena Lian (Jackson lab) and Jebrail Dempsey (Hemming-Schroeder & Foy labs), were each awarded a 2024-25 VPR Graduate fellowship.
Antimalarial drugs show potential for treating chronic lung infections caused by Mycobacterium abscessus, which would improve the quality of life for patients with limited treatment options.
Mary Jackson joined the Conviction et Engagement Avec la Fondation Raoul-Follereau podcast to discuss state of funding for leprosy research.
Using the only approved TB vaccine, Mary Jackson and her research team are developing a novel COVID-19 vaccine candidate.
On International Women’s Day, CSU celebrate the contributions and impact of women everywhere.
Animal research, including adaption of an existing TB vaccine, greatly contribute to the understanding of and response to SARS-COV-2.
CSU infectious disease scientists are continuing efforts on four unique projects to develop a possible COVID-19 vaccine.